SynthesisEBioMedicine2023

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases.

Miro E Raeber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.